Latest News

Held under the patronage of Kenya’s Ministry of Health, the three day exhibition runs until September 18 and has attracted more than 5,500 attendees and 200 exhibitors from over 30 countries.

An estimated 1.9 million people are currently living with dementia in the WHO African Region, with the number expected to increase as populations grow and life expectancy rises.

As Chief Executive Officer, Dr Kimbui will lead the Association’s operations as it continues to represent doctors and engage on healthcare issues in Kenya.

The deal builds on a relationship between the companies that began in 2014, including previous transfers of mature medicines from Sanofi to Cheplapharm.

WHO Representative to Ethiopia, the African Union and the United Nations Economic Commission for Africa, Professor Francis Chisaka Kasolo, held a bilateral meeting with EFDA Director General Heran Gerba to discuss measures to improve health product regulation.

Under the new agreement, Ori will work with its partner to modernise the manufacturing process for an autologous cell therapy.

QurCan will focus on developing and optimising genetic therapeutics using its delivery technology, while Lilly will take responsibility for advancing selected candidates through subsequent development stages.

The partnership complements existing mechanisms for supplying generic versions of lenacapavir and aims to address gaps in HIV prevention across the region.

Sessions will examine the use of generative AI to develop drug candidates, quantum computing for genomic analysis and deep learning models for assessing disease risk across national populations.

It builds on an earlier MoU signed by the two organisations in 2022 and sets out areas for deeper collaboration on health system strengthening and emerging health challenges.